SALUBRIS Trademark
SALUBRIS is a USPTO trademark filed by SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD.. Status: Registered.
Trademark Facts
| Mark | SALUBRIS |
|---|---|
| Serial Number | 88133406 |
| Registration Number | 5952886 |
| Status | Registered |
| Filing Date | 2018-09-26 |
| Registration Date | 2020-01-07 |
| Mark Type | Word |
| Nice Classes | 005 (Pharmaceuticals) |
| Owner | SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD. |
| Attorney of Record | Timothy T. Wang |
| Prosecution Events | 31 |
| Latest Event | REM1 on 2025-01-07 |
Goods & Services
Pharmaceutical preparations for use in treating diseases of the cardiovascular system and cerebrovascular system; Pharmaceutical preparations for use in treating cancerous tumors; Pharmaceutical preparations for use in treating metabolic diseases and diseases of the immune system and the musculo-skeletal system; Chemical preparations for pharmaceutical or medical purposes, namely, Pharmaceutical preparations for use in haematology, dermatology, ophthalmology and gastroenterology, Pharmaceutical preparations being anti-infectives, Pharmaceutical preparations for use in treating diseases of the respiratory system, the digestive system, and the endocrine system, Pharmaceutical preparations for use in treating hypersensitivity diseases; Medicines for human purpose for treating disease, namely, pharmaceutical preparations for use in treating diseases of the cardiovascular system and cerebrovascular system, pharmaceutical preparations for use in treating cancerous tumors, pharmaceutical preparations for use in treating metabolic diseases, as well as diseases of the immune system and the musculo-skeletal system; Active pharmaceutical ingredients in the nature of pharmaceutical preparations used for the prevention and treatment of disorders of the nervous system, the immune system, the cardiovascular system, the cerebrovascular system, the metabolic system, and the musculo-skeletal system, and for treating cancerous tumors; Biochemical medicines for use in treating diseases of the cardiovascular system and cerebrovascular system; Biochemical medicines for use in treating cancerous tumors; Biochemical medicines for use in treating metabolic diseases, nervous system diseases as well as diseases of the immune system and the musculo-skeletal system; Drugs for medical purposes, namely, pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the metabolic system, the respiratory system, and the musculo-skeletal system, pharmaceutical preparations for use in tissue and organ transplantation, for use in ophthalmology and for use in treatment of gastroenterological disorders